Mark Landon

Mark Landon is a seasoned scientist currently engaged in preclinical development at ArsenalBio since June 2023. Prior experience includes a progressive tenure at Fate Therapeutics Inc since January 2020, where Mark has held multiple titles, culminating in Senior Research Associate, and has focused on improving methods to determine immune cell identity, purity, and potency. Prior roles include Scientist II at Thermo Fisher Scientific, Graduate Research Assistant at California Polytechnic State University-San Luis Obispo, and Junior Specialist at the University of California, Santa Cruz, where contributions to research on macrophages and hematopoietic stem cells were made. Mark earned a Master of Science in Biomedical Engineering with a specialization in Regenerative Medicine and a Bachelor of Science in Biomolecular Engineering.